Podcasts

Unpacking Schizophrenia: Making the Diagnosis

12/16/2018

In part 1 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses the 5 criteria used to help diagnose schizophrenia, as well as the differential diagnosis.

Discover more insight from your peers in our Behavioral Neurology Excellence Forum.

Robert S. Laitman, MD, is an internal medicine physician at Bronx Westchester Medical Group in New York. He is on the Board of Directors for the Schizophrenia and Related Disorders Alliance of America, and is also a board member of the National Alliance of Mental Illness - New York. Over the last 10 years, he has developed a practice taking care of people with psychotic disorders after his son received a diagnosis of schizophrenia in 2006.

Dr Laitman, his family, and his colleague authored the book, "Clozapine: Meaningful Recovery from Schizophrenia."

Reference:
Schizophrenia. National Institute of Mental Health. Page last updated May 2018. https://www.nimh.nih.gov/health/statistics/schizophrenia.shtml. Accessed on November 28, 2018.

Migraine CME Series

Module 8 – Implementing Shared Decision-Making and Developing Personalized Treatment Plans

Module 7 – Addressing Patient Barriers in the Prevention of Chronic Migraine

Module 6 – The Role of Nonpharmacologic Treatment Approaches for the Prevention of Chronic Migraine

Module 5 – Pharmaceutical Treatments for Chronic Migraine Prophylaxis

Module 4 - New Therapeutic Targets in the Prevention of Chronic Migraine

Module 3 – Avoiding Medication Overuse Headache

Module 2 - Quality-of-Life Concerns in Patients With Migraine

Module 1 – Caring for Patients With Migraine in the COVID-19 Era: Focus on Teleneurology

News

an illustration of a brain against a black background, with a red area representing stroke.

News

Tenecteplase Suitable for Patients With Acute Ischemic Stroke

09/19/2024

Jolynn Tumolo ;

In patients with acute ischemic stroke eligible for intravenous thrombolysis within 4.5 hours of symptom onset, tenecteplase was noninferior to alteplase for achieving an excellent functional outcome at day 90.

In patients with acute ischemic...

09/19/2024

Neurology

News

Phase 3 Studies Find Mixed Results for Investigational MS Drug

09/18/2024

Jolynn Tumolo ;

An investigational drug for patients with multiple sclerosis (MS) yielded mixed results in a trio of phase 3 trials.

An investigational drug for...

09/18/2024

Neurology

A woman holds her forehead in pain with a migraine

News

Single-Dose Infusion Reduces Migraine Frequency in Phase 2 Trial

09/13/2024

Jolynn Tumolo ;

Intravenous Lu AG09222 reduced migraine frequency over 4 weeks in patients who had failed to find relief with previous treatments, according to a phase 2 trial published in the New England Journal of Medicine.

Intravenous Lu AG09222 reduced...

09/13/2024

Neurology

a scientist works with biomarkers in a lab

News

DYNE-251 for DMD Yields Promising Biomarker, Functional Results in Early-Stage Trial

09/10/2024

Jolynn Tumolo ;

Patients with Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping demonstrated unprecedented dystrophin expression and functional improvement with the investigational therapeutic DYNE-251.

Patients with Duchenne muscular...

09/10/2024

Neurology

News

Increasing Depression Symptoms in Older Adults Associated With Amyloid Accumulation

09/09/2024

Brionna Mendoza ;

Increasing depression symptoms in older adults were associated with early amyloid accumulation in regions responsible for emotional control, and may foretell later Alzheimer Disease (AD) development

Increasing depression symptoms...

09/09/2024

Psych Congress Network

News

Patients with Multiple Sclerosis Less Likely to Develop Alzheimer Disease

09/03/2024

Jolynn Tumolo ;

Patients with MS had about half the rate of amyloid pathology compared with matched control subjects in the Washington University School of Medicine study.

Patients with MS had about half...

09/03/2024

Neurology

an older adult lies in a hospital bed with head turned looking out of a window

News

Suvorexant Associated With Lower Delirium Rates in Some Hospitalized Older Adults

08/29/2024

Jolynn Tumolo ;

Suvorexant, a sleep-promoting orexin receptor antagonist, was associated with lower rates of delirium than placebo in hospitalized older adults at high risk of delirium, but the difference was not statistically significant.

Suvorexant, a sleep-promoting...

08/29/2024

Psych Congress Network

News

No Link Found Between Migraine and Parkinson Disease, Contrary to Previous Findings

08/28/2024

Brionna Mendoza ;

A new cohort study involving female participants found no link between migraine and later Parkinson disease (PD) development. Findings from the study were published in Neurology.

A new cohort study involving...

08/28/2024

Neurology

a young boy sits and works at a desk in a classroom

News

Back-to-School Season Overshadowed By Ongoing Stimulant Med Shortages

08/27/2024

Brionna Mendoza ;

As millions of Americans, both children and adult, prepare to return to school next week, an ongoing challenge has once again reared its head: a shortage of stimulant drugs used to treat attention-deficit/hyperactivity disorder (ADHD).

As millions of Americans, both...

08/27/2024

Psych Congress Network

News

New-Onset Anxiety Increases PD Risk in Adults 50 and Older

08/27/2024

Jolynn Tumolo ;

The risk of developing Parkinson disease (PD) is doubled in adults 50 and older with new-onset anxiety compared with those without anxiety, according to a study published in the British Journal of General Practice.

The risk of developing Parkinson...

08/27/2024

Neurology

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources

11/19/2020

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 

Early Alzheimer’s Disease:...

11/19/2020

Neurology

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources

11/19/2020

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series

Early Alzheimer’s Disease:...

11/19/2020

Neurology

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources

11/19/2020

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...

Early Alzheimer’s Disease:...

11/19/2020

Neurology

Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data

11/17/2020

Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 

Emerging Treatments for Early...

11/17/2020

Neurology

Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data

11/17/2020

Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series

Emerging Treatments for Early...

11/17/2020

Neurology

Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data

11/17/2020

Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...

Emerging Treatments for Early...

11/17/2020

Neurology

Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action

11/12/2020

Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 

Emerging Treatments for Early...

11/12/2020

Neurology

Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology

11/12/2020

Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series

Early Alzheimer’s Disease...

11/12/2020

Neurology

Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action

11/12/2020

Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...

Emerging Treatments for Early...

11/12/2020

Neurology

Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease

11/10/2020

Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 

Current Treatment Limitations...

11/10/2020

Neurology

Unpacking Schizophrenia: Making the Diagnosis

Migraine CME Series

News

Alzheimer's Disease CME Series

Specialties

Events

Year Round Education

HMP Global Products